CORFO grants Merken Biotech for preclinical radiopharmacy.
The Chilean Economic Development Agency (CORFO) has awarded to Merken Biotech with the CORFO Innova Alta Tecnología 2024 grant (24IAT-262307) to develop the “CaPTeR technology” for the treatment of advanced pancreatic cancer. The awarded grant will be led by Sebastian Belmar Willatt and will...
Read More